Hu Zhen-Hua, Liu Zhe, Zheng Gai-Fang, Li Zhan-Wen, Liu Sheng-Qun
Department of Anesthesiology, Henan Provincial People's Hospital, Henan University, China.
Front Surg. 2022 Jul 28;9:862632. doi: 10.3389/fsurg.2022.862632. eCollection 2022.
This study was performed to assess the postoperative recovery outcomes in obese patients undergoing general anesthesia.
The eligible studies were identified from PubMed, EmBase, and the Cochrane library until December 2020. The standard mean differences (SMDs) with 95% confidence intervals (CIs) were used to calculate the role of desflurane, sevoflurane, and propofol on recovery outcomes, and the analyses using the random-effects model.
Eleven randomized controlled trials involving 713 obese patients undergoing general anesthesia were selected for final meta-analysis. We noted desflurane was associated with a shorter time to eye-opening than sevoflurane (SMD: -0.86; 95% CI, -1.43 to -0.28; = 0.003). The use of desflurane with shorter time to extubation as compared with propofol (SMD: -1.13; 95% CI, -1.52 to -0.73; < 0.001) or sevoflurane (SMD: -1.19; 95% CI, -2.15 to -0.22; = 0.016), while sevoflurane was associated with longer time to extubation as compared with propofol (SMD: 1.47; 95% CI, 1.03 to 1.91; < 0.001). Desflurane were associated with shorter time to stating name as compared with propofol (SMD: -1.40; 95% CI, -2.32 to -0.48; = 0.003) or sevoflurane (SMD: -2.09; 95% CI, -3.33 to -0.85; = 0.001). In addition, desflurane was associated with a longer time for orientation to place as compared with propofol (SMD: 0.65; 95% CI, 0.22 to 1.07; = 0.003), while desflurane with shorter time for orientation to place as compared with sevoflurane (SMD: -0.88; 95% CI, -1.46 to -0.30; = 0.003).
The use of desflurane could provide better recovery outcomes in obese patients undergoing general anesthesia. Further large-scale trials should be comparison the long-term effectiveness of various anesthetics.
本研究旨在评估接受全身麻醉的肥胖患者术后恢复情况。
截至2020年12月,从PubMed、EmBase和Cochrane图书馆中检索符合条件的研究。采用95%置信区间(CI)的标准平均差(SMD)来计算地氟烷、七氟烷和丙泊酚对恢复情况的作用,并使用随机效应模型进行分析。
最终纳入11项随机对照试验,共713例接受全身麻醉的肥胖患者进行荟萃分析。我们发现,与七氟烷相比,地氟烷的睁眼时间更短(SMD:-0.86;95%CI,-1.43至-0.28;P = 0.003)。与丙泊酚(SMD:-1.13;95%CI,-1.52至-0.73;P < 0.001)或七氟烷(SMD:-1.19;95%CI,-2.15至-0.22;P = 0.016)相比,地氟烷的拔管时间更短,而与丙泊酚相比,七氟烷的拔管时间更长(SMD:1.47;95%CI,1.03至1.91;P < 0.001)。与丙泊酚(SMD:-1.40;95%CI,-2.32至-0.48;P = 0.003)或七氟烷(SMD:-2.09;95%CI,-3.33至-0.85;P = 0.001)相比,地氟烷的说出姓名时间更短。此外,与丙泊酚相比,地氟烷的定向至地点时间更长(SMD:0.65;95%CI,0.22至1.07;P = 0.003),而与七氟烷相比,地氟烷的定向至地点时间更短(SMD:-0.88;95%CI,-1.46至-0.30;P = 0.003)。
在接受全身麻醉的肥胖患者中,使用地氟烷可提供更好的恢复效果。应进行进一步的大规模试验来比较各种麻醉剂的长期有效性。